Heron Therapeutics, Inc. (LON:0J4V)
London · Delayed Price · Currency is GBP · Price in USD 1.140
-0.060 (-4.97%)
Feb 12, 2026, 3:01 PM GMT
Heron Therapeutics Employees
Heron Therapeutics had 122 employees as of December 31, 2024. The number of employees decreased by 4 or -3.17% compared to the previous year.
Employees
122
Change (1Y)
-4
Growth (1Y)
-3.17%
Revenue / Employee
945.76K GBP
Profits / Employee
-82.80K GBP
Market Cap
154.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 122 | -4 | -3.17% |
| Dec 31, 2023 | 126 | -77 | -37.93% |
| Dec 31, 2022 | 203 | -99 | -32.78% |
| Dec 31, 2021 | 302 | 79 | 35.43% |
| Dec 31, 2020 | 223 | -8 | -3.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Tristel | 267 |
| Diaceutics | 213 |
| Animalcare Group | 201 |
| Shield Therapeutics | 63 |
Heron Therapeutics News
- 21 days ago - FINANCIAL CONSULATE, INC Sells 500 Shares of Heron Therapeutics Inc (HRTX) - GuruFocus
- 4 weeks ago - Heron Therapeutics (HRTX) Surpasses Q4 Revenue Expectations - GuruFocus
- 4 weeks ago - HRTX Reports Strong Q4 2025 Revenue Growth Driven by Acute Care Products - GuruFocus
- 4 weeks ago - Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - GlobeNewsWire
- 2 months ago - Heron Therapeutics (HRTX) Gains Recognition for APONVIE in PONV Management - GuruFocus
- 2 months ago - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) - GlobeNewsWire
- 3 months ago - Heron Therapeutics: Stagnant Cash Cow, Blockbuster That Wasn't - Steer Clear - Seeking Alpha
- 3 months ago - Heron Therapeutics Inc (HRTX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - GuruFocus